These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 24096148)
1. Review of mass spectrometry-based metabolomics in cancer research. Liesenfeld DB; Habermann N; Owen RW; Scalbert A; Ulrich CM Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2182-201. PubMed ID: 24096148 [TBL] [Abstract][Full Text] [Related]
2. Metabolomics: a revolution for novel cancer marker identification. Bu Q; Huang Y; Yan G; Cen X; Zhao YL Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059 [TBL] [Abstract][Full Text] [Related]
3. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer. Liang Q; Wang C; Li B Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916 [TBL] [Abstract][Full Text] [Related]
4. In Situ Metabolomics in Cancer by Mass Spectrometry Imaging. Buck A; Aichler M; Huber K; Walch A Adv Cancer Res; 2017; 134():117-132. PubMed ID: 28110648 [TBL] [Abstract][Full Text] [Related]
5. A review of validated biomarkers obtained through metabolomics. López-López Á; López-Gonzálvez Á; Barker-Tejeda TC; Barbas C Expert Rev Mol Diagn; 2018 Jun; 18(6):557-575. PubMed ID: 29808702 [TBL] [Abstract][Full Text] [Related]
6. Clinical applications of metabolomics in oncology: a review. Spratlin JL; Serkova NJ; Eckhardt SG Clin Cancer Res; 2009 Jan; 15(2):431-40. PubMed ID: 19147747 [TBL] [Abstract][Full Text] [Related]
7. Metabolomics study of oral cancers. Chen X; Yu D Metabolomics; 2019 Feb; 15(2):22. PubMed ID: 30830419 [TBL] [Abstract][Full Text] [Related]
8. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer. Long NP; Yoon SJ; Anh NH; Nghi TD; Lim DK; Hong YJ; Hong SS; Kwon SW Metabolomics; 2018 Aug; 14(8):109. PubMed ID: 30830397 [TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research. Zhang A; Sun H; Yan G; Wang P; Wang X Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660 [TBL] [Abstract][Full Text] [Related]
10. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform. Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828 [TBL] [Abstract][Full Text] [Related]
11. Metabolomics of cancer. Serkova NJ; Glunde K Methods Mol Biol; 2009; 520():273-95. PubMed ID: 19381962 [TBL] [Abstract][Full Text] [Related]
12. High-throughput metabolomics for discovering metabolic biomarkers from intestinal tumorigenesis in APC Guo XD; Liu L; Xiao HY J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():131-139. PubMed ID: 30316137 [TBL] [Abstract][Full Text] [Related]
13. Nutritional Metabolomics in Cancer Epidemiology: Current Trends, Challenges, and Future Directions. McGee EE; Kiblawi R; Playdon MC; Eliassen AH Curr Nutr Rep; 2019 Sep; 8(3):187-201. PubMed ID: 31129888 [TBL] [Abstract][Full Text] [Related]
14. Metabolomic studies of human gastric cancer: review. Jayavelu ND; Bar NS World J Gastroenterol; 2014 Jul; 20(25):8092-101. PubMed ID: 25009381 [TBL] [Abstract][Full Text] [Related]
15. Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Ganti S; Taylor SL; Abu Aboud O; Yang J; Evans C; Osier MV; Alexander DC; Kim K; Weiss RH Cancer Res; 2012 Jul; 72(14):3471-9. PubMed ID: 22628425 [TBL] [Abstract][Full Text] [Related]
16. Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review. Zhang F; Zhang Y; Zhao W; Deng K; Wang Z; Yang C; Ma L; Openkova MS; Hou Y; Li K Oncotarget; 2017 May; 8(21):35460-35472. PubMed ID: 28389626 [TBL] [Abstract][Full Text] [Related]
17. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery. Lindahl A; Forshed J; Nordström A Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198 [TBL] [Abstract][Full Text] [Related]
18. Salivary metabolomics for cancer detection. Sugimoto M Expert Rev Proteomics; 2020 Sep; 17(9):639-648. PubMed ID: 33140667 [No Abstract] [Full Text] [Related]